Huangqi Q. Duan

1665 Kongjiang Road
Yangpu, 200092, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Cuproptosis-Related lncRNAs Modulate the Prognosis of MIBC by Regulating the Expression Pattern of Immunosuppressive Molecules Within the Tumor Microenvironment.

Cuproptosis-Related lncRNAs Modulate the Prognosis of MIBC by Regulating the Expression Pattern of Immunosuppressive Molecules Within the Tumor Microenvironment.

Journal: International journal of general medicine

Published: September 03, 2023

LRRK2 aggravates kidney injury through promoting MFN2 degradation and abnormal mitochondrial integrity.

LRRK2 aggravates kidney injury through promoting MFN2 degradation and abnormal mitochondrial integrity.

Journal: Redox biology

Published: June 29, 2023

Anlotinib Enhances the Therapeutic Effect of Bladder Cancer with GSDMB Expression: Analyzed from TCGA Bladder Cancer Database & Mouse Bladder Cancer Cell Line.

Anlotinib Enhances the Therapeutic Effect of Bladder Cancer with GSDMB Expression: Analyzed from TCGA Bladder Cancer Database & Mouse Bladder Cancer Cell Line.

Journal: Pharmacogenomics and personalized medicine

Published: November 30, 2022

Revealing prognostic and tumor microenvironment characteristics of cuproptosis in bladder cancer by genomic analysis.

Revealing prognostic and tumor microenvironment characteristics of cuproptosis in bladder cancer by genomic analysis.

Journal: Frontiers in genetics

Published: July 19, 2022

Peripheral tuberculin purified protein derivative specific T cell immunoreactivity dynamics in non-muscle invasive bladder cancer patients receiving bacillus Calmette-Guerin instillation treatment.

Peripheral tuberculin purified protein derivative specific T cell immunoreactivity dynamics in non-muscle invasive bladder cancer patients receiving bacillus Calmette-Guerin instillation treatment.

Journal: Frontiers in oncology

Published: April 24, 2022

Early-like differentiation status of systemic PD-1+CD8+ T cells predicts PD-1 blockade outcome in non-small cell lung cancer.

Early-like differentiation status of systemic PD-1+CD8+ T cells predicts PD-1 blockade outcome in non-small cell lung cancer.

Journal: Clinical & translational immunology

Published: October 18, 2021

Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer.

Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer.

Journal: International journal of general medicine

Published: September 29, 2021

The combination therapy of Everolimus and anti-PD-1 improves the antitumor effect by regulating CD8+ T cells in bladder cancer.

The combination therapy of Everolimus and anti-PD-1 improves the antitumor effect by regulating CD8+ T cells in bladder cancer.

Journal: Medical oncology (Northwood, London, England)

Published: September 17, 2021

Ischemic Preconditioning Alleviates Mouse Renal Ischemia/Reperfusion Injury by Enhancing Autophagy Activity of Proximal Tubular Cells.

Ischemic Preconditioning Alleviates Mouse Renal Ischemia/Reperfusion Injury by Enhancing Autophagy Activity of Proximal Tubular Cells.

Journal: Kidney diseases (Basel, Switzerland)

Published: September 02, 2021

Serum Metabolite Biomarkers Predictive of Response to PD-1 Blockade Therapy in Non-Small Cell Lung Cancer.

Serum Metabolite Biomarkers Predictive of Response to PD-1 Blockade Therapy in Non-Small Cell Lung Cancer.

Journal: Frontiers in molecular biosciences

Published: March 10, 2021

Partial inhibition of activin receptor-like kinase 4 alleviates bladder fibrosis caused by bladder outlet obstruction.

Partial inhibition of activin receptor-like kinase 4 alleviates bladder fibrosis caused by bladder outlet obstruction.

Journal: Experimental cell research

Published: January 21, 2021

Peripheral CD4+ T cell signatures in predicting the responses to anti-PD-1/PD-L1 monotherapy for Chinese advanced non-small cell lung cancer.

Peripheral CD4+ T cell signatures in predicting the responses to anti-PD-1/PD-L1 monotherapy for Chinese advanced non-small cell lung cancer.

Journal: Science China. Life sciences

Published: October 26, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026